11 Jan 2017 07:00
Omega Diagnostics Group PLC
("Omega" or the "Company")
ISO accreditation for manufacturing facility in Pune, India
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that its fully owned Indian subsidiary, Omega Dx (Asia) Pvt. Ltd has received certificates of accreditation from BSI confirming its Quality Management System is compliant with ISO 9001:2008 and ISO 13485:2003.
The accreditation covers the manufacturing facility in Pune and ensures that product originating from this site is designed, manufactured and supplied to internationally recognised quality standards. This milestone is an important pre-requisite for CE-Marking the malaria and pregnancy tests produced at this site. CE-Marking is still expected to be achieved by the end of the current financial year.
Accreditation also means that products can be supplied for the Indian domestic market with immediate effect and the first commercial sale of one of the Company's malaria tests has now been achieved.
Andrew Shepherd, Chief Executive Officer of the Company commented: "We are pleased to have reached this milestone on schedule and look forward to generating a return from the investment to date in this facility."
Contacts:
Omega Diagnostics Group PLC | Tel: 01259 763 030 |
Andrew Shepherd, Chief Executive | www.omegadiagnostics.com |
Kieron Harbinson, Group Finance Director | |
Jag Grewal, Group Sales and Marketing Director |
|
finnCap Ltd | Tel: 020 7220 0500 |
Geoff Nash/James Thompson (Corporate Finance) | |
Mia Gardner (Corporate Broking) | |
Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |